Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study.

Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis. 2003; 16(4):389-95.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Cholesterol
Double-Blind Method
Endpoint Determination
Female
Heptanoic Acids
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Male
Middle Aged
Multicenter Studies as Topic
Patient Selection
Prospective Studies
Pyrroles
Randomized Controlled Trials as Topic
Research Design
Secondary Prevention
Stroke

authors with profiles

Larry Goldstein